This review highlights recent discoveries that improve our understanding of the pathophysiological NOTCH1 signaling in CLL and the clinical impact of NOTCH1 mutations in retrospective and prospective trials. This evidence concerns the gene NOTCH1 and B-cell chronic lymphocytic leukemia.